TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KINIKSA PHARMACEUTIC A (KNSA) insider trades

KINIKSA PHARMACEUTIC A (KNSA) insider trading activity (SEC Form 4). Over the trailing 90 days, KNSA insiders filed 0 purchases totalling $0 and 6 sales totalling $77.1M — net SELLING of $77.1M. Most recent filing: Nov 6, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$77.1M
Net (90d)
-$77.1M
net selling
Most recent
Nov 6, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 6, 2026Patel Sanj KCOB, CEOS SaleOE—$94.71$14.3Mfiling
Nov 3, 2026Ragosa MarkCFOS SaleOE—$92.16$3.4Mfiling
Nov 3, 2026Patel Sanj KCOB, CEOS SaleOE—$92.92$37.4Mfiling
Nov 3, 2026Paolini John F.CHIEF MEDICAL OFFICERS SaleOE—$93.09$8.9Mfiling
Nov 3, 2026Moat RossCOOS SaleOE—$92.93$9.6Mfiling
Nov 3, 2026Megna Michael RCHIEF ACCOUNTING OFFICERS SaleOE—$94.43$3.4Mfiling
Jul 31, 2026Cole G BradleyDirS Sale—$81.43$299Kfiling